Ceftazidime resistance among selected nosocomial gram-negative bacilli in the united states

Journal of Infectious Diseases

Volumn 170, Issue 6, 1994, Pages 1622-1625

  Burwen, Dale R ^a,b   Banerjee, Shailen N ^a   Gaynes, Robert P ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; ENTEROBACTER; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INTENSIVE CARE; KLEBSIELLA PNEUMONIAE; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RISK FACTOR; UNITED STATES;

CEFTAZIDIME; CEPHALOSPORIN RESISTANCE; CROSS INFECTION; ENTEROBACTER; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HOSPITALS, TEACHING; HUMAN; INTENSIVE CARE UNITS; KLEBSIELLA PNEUMONIAE; LOGISTIC MODELS; PSEUDOMONAS AERUGINOSA; UNITED STATES;

EID: 0028063601     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/170.6.1622     Document Type: Article

References (14)

1. Emori TG, Gaynes RP. An overview of nosocomial infections including the role for the microbiology laboratory. Clin Microbiol Rev 1993;6:428-42.
2. Sirot D, Sirot J, Labia R, et al. Transferable resistance to third genera-tion Cephalosporins in clinical isolates of Klebsiella pneumoniae: Identification of CTX-1. a novel /3-lactamase. J Antimicrob Che-mother 1987;20:323-34.
3. US Department of Health and Human Services. Approved drug products with therapeutic equivalence evaluations. 13th ed. Washington, DC: USDHHS Public Health Service, Food and Drug Administration, 1993.
4. Bure A, Legrand P, Arlet G, Jarlier V, Paul G, Philippon A. Dissemination in five French hospitals of Klebsiella pneumoniae serotype K.25 harboring a new transferable enzymatic resistance to third generation cephalosporins and aztreonam. Eur J Clin Microbiol Infect Dis 1988;7:780-2.
5. Gutmann L, Ferre B, Goldstein FW, et al. SHV-5, a novel SHV-type /3-lactamase that hydrolyzes broad-spectrum cephalosporins and monobactams. Antimicrob Agents Chemother 1989;33:951-6.
6. Quinn JP, Miyashiro D, Sahm D, Flamm R. Bush K. Novel plasmidmediated /3-lactamase (TEM-10) conferring selective resistance to ceftazidime and aztreonam in clinical isolates of Klebsiella pneumoniae. Antimicrob Agents Chemother 1989;33:1451-6.
7. Rice LB, Willey SH, Papanicolaou GA, et al. Outbreak of ceftazidime resistance caused by extended-spectrum 3-lactamases at a Massachusetts chronic-care facility. Antimicrob Agents Chemother 1990;34:2193-9.
8. Meyer K.S, Urban C. Eagan JA, Berger BJ, Rahal JJ. Nosocomial outbreak of Klebsiella infection resistant to late-generation cephalosporins. Ann Intern Med 1993; 1 19:353-8.
9. Sirot DL, Goldstein FW, Soussy CJ, et al. Resistance to cefotaxime and seven other /3-lactams in members of the family Enterobacteriaceae: A 3-year survey in France. Antimicrob Agents Chemother 1992;36:1677-81.
10. Emori TG. Culver DH. Horan TC, et al. National Nosocomial Infections Surveillance (NNIS) system: Description of surveillance methodology. Am J Infect Control 1991;19:19-35.
11. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM. CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988;16:128-40.
12. Snedecor GW, Cochran WG. Statistical methods. 7th ed. Ames, 1A: Iowa State University Press, 1980.
13. Monnet D, Edwards JE, Gaynes R. Extended spectrum beta-lactam resistant nosocomial Klebsiella pneumoniae: Epidemiologic evidence of interhospital transmission [abstract]. Infect Control Hosp Epidemiol 1994; 15(suppl):23.
14. Gaynes RP, Culver DH, National Nosocomial Infections Surveillance System. Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol 1992;13:10-4